Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Zhengyao Biotechnology Co., Ltd. is a China-based pharmaceutical and biotechnology company focused on the research, development, and production of high-quality medicinal products. The company operates modern manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards, ensuring the safety and efficacy of its diverse product portfolio. Anhui Zhengyao's business scope encompasses the development of small molecule drugs, peptide-based therapeutics, and various health-related biological products. By integrating advanced R&D with large-scale production capabilities, the company aims to address unmet medical needs in areas such as infectious diseases and metabolic health. Anhui Zhengyao is committed to innovation and quality, positioning itself as a significant player in the regional life sciences ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 安徽正药.